See what is happening
Stay up to date with everything Striatech. Online events, conferences, latest product news, interesting publications of our customers... Here you find everything in one place.
16 Jan 2026
Let Us Highlight Your Research
Striatech regularly shares concise summaries of recent publications where our solutions for neuroscience testing have been used. Now we’d love to feature your work and highlight new neuroscience insights.
19 Dec 2025
Looking Back on 2025: Progress, Collaboration and Connections
2025 was a year of progress, collaboration and exchange within the vision science community. We are grateful for the trust of our partners and collaborators worldwide and proud to support new discoveries – including our continued contribution to the PRO RETINA Foundation, advancing research and patient care. With new projects on the horizon, we look forward to continuing this journey together in 2026.
Journal Club
18 Nov 2025
Journal Club: Gene-Agnostic Gene Therapy to Preserve Vision
This Journal Club features innovative research by Harvard’s Cepko lab, exploring gene-independent strategies to preserve vision in retinitis pigmentosa and other genetic forms of blindness. Using AAVs to enhance metabolic support, including MCT2 expression in retinal pigment epithelial cells, they preserved cone photoreceptors and maintained color and daylight vision across diverse genotypes.
Publication
11 Nov 2025
Enhancing Retinal Metabolism Protects Cone Vision
This study by Chandler et al explores a gene-independent approach to preserve vision in retinitis pigmentosa (RP), a genetic disorder causing photoreceptor degeneration. By boosting MCT2 protein in retinal pigment epithelial cells, they enhanced glucose availability and reduced glycolysis, improving cone photoreceptor survival in RP models. This metabolic support strategy could help maintain vision in RP patients regardless of their specific genetic mutation. The OptoDrum provided quantitative measurements of visual function and confirming the therapy’s effectiveness in slowing retinal degeneration.
23 Sep 2025
EVER 2025: Visit Us at Booth #2
Meet Striatech at EVER 2025 in Florence – you can find us at at the booth of our partner Phoenix Micron (#2) and discover how our solutions can support your studies and experiments.
Publication
30 Aug 2025
When Brain Defenders Turn Destructive: How Microglia and T Cells Promote Age-Related Decline
As we get older, immune cells in the brain called microglia can become overactive and attract aggressive CD8+ T cells. These T cells then attack the brain’s axons’ protective layer, known as myelin, leading to its damage and a decline in brain function. Groh et al reveal the chain reaction behind these age-related brain changes and point to new opportunities for preventing or slowing down brain degeneration. The OptoDrum assay confirmed the link between axon degeneration and behavioral vision deficits.
8 Aug 2025
Meet the Striatech Team
Meet the Striatech Team!
Every company has a story and ours is shaped by the passionate individuals behind Striatech. Herewith, we introduce you to our team—the researchers, innovators, and creators driving our mission forward.
From our founders, who pioneered the OptoDrum system, to our Marketing & Sales team, who connect our technology with the research community, each member brings a unique perspective. Through this feature, we’ll share personal insights, challenges and what excites us about visual neuroscience and tech innovation.
Publication
1 Jul 2025
Validating Photoreceptor Replacement Therapy in a Severe LCA Mouse Model
Photoreceptor degeneration leads to severe vision loss in diseases like Leber congenital amaurosis (LCA). This study found that transplanting stem cell-derived human cone photoreceptors into a mouse model of LCA restored vision. The transplanted cells formed new connections with the host retina, and treated mice showed strong recovery of light responses and improved ability to track moving patterns in the OptoDrum. These results suggest cone transplantation could be a promising therapy for advanced retinal diseases.
23 May 2025
FELASA 2025: Advancing Vision Research and Animal Welfare
From June 2–5, 2025, Striatech will showcase the latest technologies for vision research at the FELASA Congress in Athens, with a special focus on animal-friendly testing methods. Discover our innovative, stress-reducing Non-Aversive Animal Platform for OptoDrum and other solutions that advance both science and animal welfare.
21 May 2025
Dedicated to Animal Welfare – New Non-Aversive Animal Platform
Striatech’s new non-aversive Animal Platform for the OptoDrum minimizes stress and promotes natural behavior—ideal for sensitive or behaviorally complex animal models. Key features include a calming transparent design, voluntary animal access via “Tunnel-Lid,” and improved handling.
Journal Club
28 Apr 2025
Journal Club: RIP1 Inhibition Protects Retinal Ganglion Cells in Preclinical Glaucoma Models
This Journal Club features innovative research by Kim et al., who revealed that inhibiting RIP1 kinase protects retinal ganglion cells in preclinical glaucoma models. Their work demonstrates that targeting necroptosis and inflammation can prevent cell loss and functional decline, directly linking genetic risk to inflammatory degeneration and highlighting RIP1 as a promising therapeutic target for neuroprotection in glaucoma.